乳腺癌放射治疗中的当前争议
Current controversies in radiotherapy for breast cancer.
作者信息
Krug David, Baumann René, Budach Wilfried, Dunst Jürgen, Feyer Petra, Fietkau Rainer, Haase Wulf, Harms Wolfgang, Piroth Marc D, Sautter-Bihl Marie-Luise, Sedlmayer Felix, Souchon Rainer, Wenz Frederik, Sauer Rolf
机构信息
Department of Radiation Oncology, University Hospital Heidelberg and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
University Hospital Schleswig-Holstein, Kiel, Germany.
出版信息
Radiat Oncol. 2017 Jan 23;12(1):25. doi: 10.1186/s13014-017-0766-3.
Abstract
Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).
摘要
在过去几十年中，多模式治疗方法显著改善了乳腺癌患者的治疗效果。放射治疗是多模式治疗理念的一个组成部分，在从原位导管癌（DCIS）等前驱病变到晚期乳腺癌的众多临床情况下，用于根治性和姑息性治疗目的。本综述探讨了放射治疗中当前存在争议的话题，特别考虑了DCIS、加速部分乳腺照射（APBI）和区域淋巴结照射（RNI），并提供了德国放射肿瘤学会（DEGRO）乳腺癌专家小组临床实践指南的最新情况。
相似文献
1
Current controversies in radiotherapy for breast cancer.乳腺癌放射治疗中的当前争议
Radiat Oncol. 2017 Jan 23;12(1):25. doi: 10.1186/s13014-017-0766-3.
2
DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.DEGRO乳腺癌放疗实用指南I：保乳治疗
Strahlenther Onkol. 2007 Dec;183(12):661-6. doi: 10.1007/s00066-007-1811-1.
3
Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ.应用加速部分乳腺照射治疗导管原位癌患者的临床结局。
Clin Breast Cancer. 2012 Aug;12(4):259-63. doi: 10.1016/j.clbc.2012.04.006. Epub 2012 Jun 1.
4
Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base.美国放射肿瘤学会发布共识指南的实际影响：加速部分乳腺照射与国家癌症数据库
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):338-48. doi: 10.1016/j.ijrobp.2015.10.059. Epub 2015 Oct 31.
5
Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.从 ASTRO 共识小组中移除导管原位癌（DCIS）是否应该谨慎？对 300 例接受加速部分乳腺照射（APBI）治疗的 DCIS 患者结局的汇总分析。
Ann Surg Oncol. 2013 Apr;20(4):1275-81. doi: 10.1245/s10434-012-2694-7. Epub 2012 Sep 29.
6
DEGRO practical guideline for partial-breast irradiation.DEGRO 部分乳房照射实践指南。
Strahlenther Onkol. 2020 Sep;196(9):749-763. doi: 10.1007/s00066-020-01613-z. Epub 2020 Apr 29.
7
Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation.美国放射肿瘤学会治疗共识专家组指南对加速部分乳腺照射应用的局限性。
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):977-84. doi: 10.1016/j.ijrobp.2009.12.047. Epub 2010 May 25.
8
Accelerated partial breast irradiation for pure ductal carcinoma in situ.单纯导管原位癌的加速部分乳房照射。
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):403-8. doi: 10.1016/j.ijrobp.2010.05.030. Epub 2010 Aug 26.
9
Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database.2003 - 2011年导管原位癌加速局部乳腺照射的应用：来自国家癌症数据库的报告
Ann Surg Oncol. 2014 Oct;21(11):3457-65. doi: 10.1245/s10434-014-3717-3. Epub 2014 May 9.
10
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways.DEGRO 实践指南：乳腺癌 III 期放疗——淋巴途径放疗。
Strahlenther Onkol. 2014 Apr;190(4):342-51. doi: 10.1007/s00066-013-0543-7. Epub 2014 Mar 5.
引用本文的文献
1
Comparison of transcriptome profiles of radiotherapy beams on MCF-7 breast cancer xenografts.放射治疗束对MCF-7乳腺癌异种移植瘤转录组图谱的比较。
Breast Cancer. 2025 Jun 27. doi: 10.1007/s12282-025-01735-1.
2
Enhancing the therapeutic impact of sublethal radiofrequency hyperthermia in malignant solid tumor treatment.增强亚致死性射频热疗在恶性实体瘤治疗中的治疗效果。
Heliyon. 2024 Apr 17;10(8):e29866. doi: 10.1016/j.heliyon.2024.e29866. eCollection 2024 Apr 30.
3
Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.在HR+/HER2- T1-2 N1M0乳腺癌患者中，谁能从乳房切除术后放疗中获益？一种基于可解释机器学习死亡率预测的方法。
Front Endocrinol (Lausanne). 2024 Feb 2;15:1326009. doi: 10.3389/fendo.2024.1326009. eCollection 2024.
4
Collapsed Cone Superposition Algorithm Validation for Chest Wall Tangential Fields using Virtual Wedge Filters.使用虚拟楔形滤过器对胸壁切线野进行塌陷锥叠加算法验证
J Med Signals Sens. 2023 Jul 12;13(3):191-198. doi: 10.4103/jmss.jmss_7_22. eCollection 2023 Jul-Sep.
5
Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer.在辅助放疗过程中循环上皮肿瘤细胞（CETC/CTC）的增加是早期乳腺癌患者预后不良的预测因子。
Curr Oncol. 2022 Dec 24;30(1):261-273. doi: 10.3390/curroncol30010021.
6
Near-infrared upconversion multimodal nanoparticles for targeted radionuclide therapy of breast cancer lymphatic metastases.近红外上转换多模态纳米粒子用于乳腺癌淋巴转移的靶向放射性核素治疗。
Front Immunol. 2022 Dec 1;13:1063678. doi: 10.3389/fimmu.2022.1063678. eCollection 2022.
7
The potential of gas plasma technology for targeting breast cancer.气体等离子体技术在靶向乳腺癌中的潜力。
Clin Transl Med. 2022 Aug;12(8):e1022. doi: 10.1002/ctm2.1022.
8
Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.乳腺癌放射治疗——第 1 个中-东欧乳腺癌专业共识声明的专业指南。
Pathol Oncol Res. 2022 Jun 23;28:1610378. doi: 10.3389/pore.2022.1610378. eCollection 2022.
9
Effect of hyaluronic acid on radiodermatitis in patients with breast cancer: a meta-analysis of randomized controlled trials.透明质酸对乳腺癌放射性皮炎患者的影响：一项随机对照试验的荟萃分析。
Support Care Cancer. 2022 May;30(5):3965-3975. doi: 10.1007/s00520-022-06828-7. Epub 2022 Jan 20.
10
Hypoxic Breast Cancer Cell-Derived Exosomal SNHG1 Promotes Breast Cancer Growth and Angiogenesis via Regulating miR-216b-5p/JAK2 Axis.缺氧乳腺癌细胞衍生的外泌体SNHG1通过调控miR-216b-5p/JAK2轴促进乳腺癌生长和血管生成。
Cancer Manag Res. 2022 Jan 7;14:123-133. doi: 10.2147/CMAR.S327621. eCollection 2022.
本文引用的文献
1
An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).一项国际随机对照试验，旨在比较早期乳腺癌女性保乳手术后靶向术中放疗（TARGIT）与传统术后放疗（TARGIT-A试验）。
Health Technol Assess. 2016 Sep;20(73):1-188. doi: 10.3310/hta20730.
2
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.前哨淋巴结转移患者行前哨淋巴结清扫术加或不加腋窝清扫术后的局部区域复发：美国外科医师学会肿瘤学组（联盟）ACOSOG Z0011随机试验的长期随访
Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863.
3
Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials.早期乳腺癌局部乳腺照射降低死亡率：随机试验的荟萃分析
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):259-265. doi: 10.1016/j.ijrobp.2016.05.008. Epub 2016 May 13.
4
Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?LORIS试验的入选标准能否识别出原位导管癌患者中升级为浸润性癌风险较低的人群？
Ann Surg Oncol. 2016 Oct;23(11):3487-3493. doi: 10.1245/s10434-016-5268-2. Epub 2016 May 12.
5
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.DEGRO乳腺癌放疗实用指南VI：局部区域乳腺癌复发的治疗
Strahlenther Onkol. 2016 Apr;192(4):199-208. doi: 10.1007/s00066-015-0939-7. Epub 2016 Mar 1.
6
Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.保乳手术后导管原位癌患者的预后评分及放疗对生存改善的影响：一项基于人群的纵向队列研究。
J Clin Oncol. 2016 Apr 10;34(11):1190-6. doi: 10.1200/JCO.2015.65.1869. Epub 2016 Feb 1.
7
CLINICAL DECISIONS. Ductal Carcinoma In Situ.临床决策。导管原位癌。
N Engl J Med. 2016 Jan 28;374(4):390-2. doi: 10.1056/NEJMclde1512213.
8
Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.乳腺癌区域淋巴结的辅助放疗——随机试验的荟萃分析——更新版
Radiat Oncol. 2015 Dec 21;10:258. doi: 10.1186/s13014-015-0568-4.
9
Radiotherapy of Ductal Carcinoma In Situ.导管原位癌的放射治疗
Breast Care (Basel). 2015 Aug;10(4):259-64. doi: 10.1159/000437452. Epub 2015 Aug 19.
10
Radiotherapy of the Lymphatic Pathways in Early Breast Cancer.早期乳腺癌淋巴途径的放射治疗
Breast Care (Basel). 2015 Aug;10(4):254-8. doi: 10.1159/000438662. Epub 2015 Aug 19.
Zotero 插件